News and Trends 16 Sep 2022
Marengo advancing its lead TCR activator into clinic after FDA clearance
Marengo Therapeutics is advancing its lead TCR activator, STAR0602, into clinic following clearance of its investigational new drug (IND) application by the U.S. Food and Drug Administration (FDA). STAR0602 is…
